PharmacyCodes



Ergotonin en es it fr

Ergotonin Brand names, Ergotonin Analogs

Ergotonin Brand Names Mixture

  • No information avaliable

Ergotonin Chemical_Formula

C33H37N5O5

Ergotonin RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Ergotonin fda sheet

Ergotonin FDA

Ergotonin msds (material safety sheet)

Ergotonin MSDS

Ergotonin Synthesis Reference

No information avaliable

Ergotonin Molecular Weight

583.678 g/mol

Ergotonin Melting Point

No information avaliable

Ergotonin H2O Solubility

No information avaliable

Ergotonin State

Solid

Ergotonin LogP

No information avaliable

Ergotonin Dosage Forms

Liquid

Ergotonin Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Ergotonin Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Ergotonin Absorption

Interpatient variable and may be dependent on the administration technique

Ergotonin side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Ergotonin Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45� (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Ergotonin Organisms Affected

Humans and other mammals